SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-18-017129
Filing Date
2018-12-10
Accepted
2018-12-10 14:38:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO SCHEDULE 13G sc13g1218a1lfwoodford_evofem.htm SC 13G/A 62581
  Complete submission text file 0001213900-18-017129.txt   64485
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Subject) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88576 | Film No.: 181225883
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O WOODFORD INVESTMENT MANAGEMENT LTD 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN
Business Address C/O WOODFORD INVESTMENT MANAGEMENT LTD 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN 0044186580 9041
LF Woodford Equity Income Fund (Filed by) CIK: 0001637243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A